Rhygaze Companies
Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.
Headquarters:
Basel, Basel-Stadt, Switzerland
Industry:
Clinical Data Management
Founded Date:
2024